Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
44
NEUP Quote, Financials, Valuation and Earnings
Last price:
$3.87
Seasonality move
:
517.18%
Day range:
$3.85 - $3.98
52-week range:
$0.23 - $21.40
Dividend yield:
0%
P/E ratio:
4.31x
P/S ratio:
14.87x
P/B ratio:
0.58x
Volume:
46.1K
Avg. volume:
133.3K
1-year change:
1455.38%
Market cap:
$7.3M
Revenue:
$15.6M
EPS (TTM):
$0.90
Earnings Data
Next earnings date for NEUP
--
Most recent earnings per share
-$4.41
Missed by $3.10
(Nov 14/2025)
Consensus Estimate
-$1.31
(Nov 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NEUP Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | -- | -- | -- | -$0.56 | -- |
| 11/14/2025 | Q3 | -- | -- | -$4.41 | -$1.31 | -$3.10 |
| 06/30/2025 | Q2 | -- | -- | -- | -$3.83 | -- |
| 03/31/2025 | Q1 | $14.9M | $15M | $6.55 | -- | -- |
| 12/31/2024 | Q4 | -- | $662.7K | -$1.23 | -- | -- |
| 11/14/2024 | Q3 | -- | -- | -$0.00 | -- | -- |
| 06/30/2024 | Q2 | -- | -- | -$29.21 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$33.98 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$63.75 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.04 | -- | -- |
Neuphoria Therapeutics, Inc. Earnings Questions
-
How Much did Neuphoria Therapeutics, Inc. Generate in Revenue Last Quarter?
Neuphoria Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Neuphoria Therapeutics, Inc. Beat Earnings Last Quarter?
Neuphoria Therapeutics, Inc. announced earnings per share of -$4.41 which represents a miss of analyst forecast a -$1.31 per share.
-
Is Neuphoria Therapeutics, Inc. Profitable?
Neuphoria Therapeutics, Inc. reported -$165.8K that represents -$0.07 per share over the last quarter.
-
What is the Analyst Consensus for Neuphoria Therapeutics, Inc. EPS Next Year?
Neuphoria Therapeutics, Inc.'s earnings are forecast to decrease from -$0.23 per share to -$4.07 per share next year representing a decrease of -1686.66%.
-
When is Neuphoria Therapeutics, Inc.'s Earnings Date?
Currently, Neuphoria Therapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 23, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
